Analysts Set Marsh & McLennan Companies, Inc. (NYSE:MRSH) Price Target at $203.56

Marsh & McLennan Companies, Inc. (NYSE:MRSH) has been given a consensus recommendation of “Hold” by the eighteen brokerages that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, ten have given a hold recommendation, six have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $203.5625.

Several research firms recently weighed in on MRSH. Bank of America decreased their price objective on shares of Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating on the stock in a research report on Tuesday, April 14th. Raymond James Financial upgraded shares of Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 price objective on the stock in a research report on Tuesday, February 17th. Wells Fargo & Company decreased their price objective on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 9th. Mizuho cut their target price on Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a research note on Monday, April 13th. Finally, Barclays cut their target price on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research note on Wednesday, April 8th.

Marsh & McLennan Companies Stock Down 0.1%

MRSH stock opened at $162.44 on Thursday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 1.28. The company’s 50 day moving average is $164.41 and its 200 day moving average is $171.56. The stock has a market cap of $78.47 billion, a price-to-earnings ratio of 20.30, a price-to-earnings-growth ratio of 2.33 and a beta of 0.62. Marsh & McLennan Companies has a 1-year low of $157.74 and a 1-year high of $235.78.

Marsh & McLennan Companies (NYSE:MRSH) last posted its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, topping the consensus estimate of $3.21 by $0.08. The company had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The business’s revenue for the quarter was up 7.6% compared to the same quarter last year. Sell-side analysts predict that Marsh & McLennan Companies will post 10.38 EPS for the current fiscal year.

Insider Transactions at Marsh & McLennan Companies

In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,655 shares of the company’s stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total value of $3,052,861.50. Following the completion of the sale, the chief executive officer owned 116,811 shares of the company’s stock, valued at $21,411,456.30. This represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.38% of the stock is currently owned by corporate insiders.

Institutional Trading of Marsh & McLennan Companies

Several hedge funds and other institutional investors have recently bought and sold shares of MRSH. Brighton Jones LLC boosted its stake in Marsh & McLennan Companies by 51.2% in the fourth quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider’s stock worth $1,856,000 after buying an additional 2,960 shares in the last quarter. Bison Wealth LLC boosted its stake in Marsh & McLennan Companies by 39.6% in the fourth quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider’s stock worth $651,000 after buying an additional 869 shares in the last quarter. Glenview Trust co boosted its stake in Marsh & McLennan Companies by 10.8% in the second quarter. Glenview Trust co now owns 3,897 shares of the financial services provider’s stock worth $852,000 after buying an additional 379 shares in the last quarter. Osterweis Capital Management Inc. boosted its stake in Marsh & McLennan Companies by 18,440.0% in the second quarter. Osterweis Capital Management Inc. now owns 927 shares of the financial services provider’s stock worth $203,000 after buying an additional 922 shares in the last quarter. Finally, Diversify Advisory Services LLC purchased a new stake in shares of Marsh & McLennan Companies during the second quarter valued at approximately $1,307,000. Hedge funds and other institutional investors own 87.99% of the company’s stock.

About Marsh & McLennan Companies

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.